Ralf Zahn

Ralf Zahn

Auto-generated profile, based on publicly available information

Ralf Zahn

Medizinische Klinik B, Klinikum der Stadt Ludwigshafen am Rhein Gemeinnützige GmbH, Heart Centre Ludwigshafen, Ludwigshafen, Germany

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 September 2010 in European Heart Journal
Verified
Journal Article
Open access
PDF file
RZRalf Zahn
Ralf Zahn
UGUlrich Gerckens
Ulrich Gerckens
EGEberhard Grube
Eberhard Grube
ALAxel Linke
Axel Linke
HSHorst Sievert
Horst Sievert
OIon behalf of the German Transcatheter Aortic Valve Interventions--Registry Investigators
on behalf of the German Transcatheter Aortic Valve Interventions--Registry Investigators
Treatment of elderly symptomatic patients with severe aortic stenosis and co-morbidities is challenging. Transcatheter aortic valve interventions [balloon valvuloplasty and transcatheter aortic valve implantation (TAVI)] are evolving as alternative treatment options to surgical valve replacement. We report the first results of the prospective multi-centre German Transcatheter Aortic Valve Interventions—Registry. Between January 2009 and December 2009, a total of 697 patients (81.4 ± 6.3 years, 44.2% males, and logistic EuroScore 20.5 ± 13.2%) underwent TAVI. Pre-operative aortic valve area was 0.6 ± 0.2 cm² with a mean transvalvular gradient of 48.7 ± 17.2 mmHg. Transcatheter aortic valve implantation was performed percutaneously in the majority of patients [666 (95.6%)]. Only 31 (4.4%) procedures were done surgically: 26 (3.7%) transapically and 5 (0.7%) transaortically. The Medtronic CoreValveTM prosthesis was used in 84.4%, whereas the Sapien EdwardsTM prosthesis was used in the remaining cases. Technical success was achieved in 98.4% with a post-operative mean transaortic pressure gradient of 5.4 ± 6.2 mmHg. Any residual aortic regurgitation was observed in 72.4% of patients, with a significant aortic insufficiency (≥Grade III) in only 16 patients (2.3%). Complications included pericardial tamponade in 1.8% and stroke in 2.8% of patients. Permanent pacemaker implantation after TAVI became necessary in 39.3% of patients. In-hospital death rate was 8.2%, and the 30-day death rate 12.4%. In this real-world registry of high-risk patients with aortic stenosis, TAVI had a high success rate and was associated with moderate in-hospital complications. However, careful patient selection and continued hospital selection seem crucial to maintain these results.

14 September 2022 in The Lancet Neurology
Verified
Journal Article
Closed access
Tilman ReiffTilman Reiff
Tilman Reiff
HEHans-Henning Eckstein
Hans-Henning Eckstein
UMUlrich Mansmann
Ulrich Mansmann
OJOlav Jansen
Olav Jansen
GFGustav Fraedrich
Gustav Fraedrich
SISPACE-2 Investigators
SPACE-2 Investigators

1 July 2013 in The American Journal of Cardiology
Verified
Journal Article
Closed access
RZRalf Zahn
Ralf Zahn
UGUlrich Gerckens
Ulrich Gerckens
ALAxel Linke
Axel Linke
HSHorst Sievert
Horst Sievert
PKPhilipp Kahlert
Philipp Kahlert
JSJochen Senges
Jochen Senges

1 September 2004 in European Heart Journal
Verified
Journal Article
Closed access
RZRalf Zahn
Ralf Zahn
BMBernd Mark
Bernd Mark
NNNikolaj Niedermaier
Nikolaj Niedermaier
UZUwe Zeymer
Uwe Zeymer
PLPeter Limbourg
Peter Limbourg
A(Arbeitsgemeinschaft Leitende Kardiologische Krankenhausärzte (Alkk)
Arbeitsgemeinschaft Leitende Kardiologische Krankenhausärzte (Alkk)
Carotid artery stenting (CAS) for carotid artery stenoses has become an alternative to carotid endarterectomy. However, CAS itself can cause cerebral ischaemic events. Embolic protection devices (PD) promise to reduce the incidence of these events. From July 1996 to March 2003, 1483 patients from 26 hospitals were included in the prospective CAS Registry of the ALKK study group. A PD was used in 668 of 1483 patients (45%). The use of a PD has grown rapidly over the years and reached 100% in 2003. Patients treated with a PD had prior carotid artery dilatation more often (3.5% versus 1%, p < 0.001), a prior myocardial infarction (34% versus 27.4%, p = 0.007) and a history of arterial hypertension (89.9% versus 78.6%, p = 0.007) compared to patients treated without a PD. A thrombus was more often visible in patients treated under distal protection (16.5% versus 8%, p < 0.001). The use of a PD led to a 10-min longer intervention (45 min versus 35 min median, p < 0.001). Patients treated with a PD had a lower rate of ipsilateral stroke (1.7% versus 4.1%, p = 0.007) and a lower rate of all non-fatal strokes and all deaths (2.1% versus 4.9%, p = 0.004) during the hospital stay. This was confirmed by multiple logistic regression analysis (adjusted OR = 0.45, 95% CI: 0.23-0.91, p = 0.026). A similar reduction could be found for symptomatic as well as asymptomatic carotid artery stenoses. Since 1996 there has been a steady increase in the use of PDs for CAS, with a 100% use in 2003. The use of a PD may lower the rate of ipsilateral strokes during CAS.

11 January 2007 in European Heart Journal
Verified
Journal Article
Open access
PDF file
RZRalf Zahn
Ralf Zahn
TIThomas Ischinger
Thomas Ischinger
MHMatthias Hochadel
Matthias Hochadel
UZUwe Zeymer
Uwe Zeymer
WSWolfgang Schmalz
Wolfgang Schmalz
F(For The Arbeitsgemeinschaft Leitende Kardiologische Krankenhausarzte (Alkk)
For The Arbeitsgemeinschaft Leitende Kardiologische Krankenhausarzte (Alkk)
Aims We tried to determine the influence of age on complication rates of carotid artery stenting (CAS).

1 June 2001 in JACC
Verified
Journal Article
Closed access
RZRalf Zahn
Ralf Zahn
RSRudolf Schiele
Rudolf Schiele
SSSteffen Schneider
Steffen Schneider
AGAnselm K Gitt
Anselm K Gitt
HWHarm Wienbergen
Harm Wienbergen
JSJochen Senges
Jochen Senges